AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Merck Sells Investment-Grade Bonds to Fund Verona Acquisition, Joins Busy Primary Market
ByAinvest
Tuesday, Sep 2, 2025 9:50 am ET1min read
Merck & Co. is selling investment-grade corporate bonds to fund its acquisition of Verona Pharma Plc. The sale, led by Bank of America, Goldman Sachs, JPMorgan Chase, and Mizuho, includes six parts, including a 30-year bond with a yield around 1 percentage point above similarly dated Treasuries. Proceeds will be used for general corporate purposes, including debt repayment. The sale comes on a busy day for the US high-grade primary market, with over 16 borrowers selling debt.
Merck & Co. is set to sell investment-grade corporate bonds today to fund its acquisition of fellow drugmaker Verona Pharma Plc. The sale, led by Bank of America, Goldman Sachs Group Inc., JPMorgan Chase & Co., and Mizuho, includes six parts, with a 30-year bond among them. Initial price discussions for this bond call for a yield around 1 percentage point above similarly dated Treasuries [1].The pharmaceutical giant's debt sale comes on a busy day in the US high-grade primary market, with over 16 borrowers selling debt, as is usual for the period following the Labor Day holiday in the US. Others so far include units of carmakers like Ford and Toyota, as well as financial institutions like HSBC and Credit Agricole [1].
Proceeds from Merck’s debt sale will be used for general corporate purposes, including repaying its outstanding debt. The acquisition of Verona, announced in July, is valued at roughly $10 billion [1].
This story was produced with the assistance of Bloomberg Automation.
References:
[1] https://www.bloomberg.com/news/articles/2025-09-02/merck-taps-us-investment-grade-bond-market-for-verona-purchase
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet